Cargando…
Terazosin Stimulates Pgk1 to Remedy Gastrointestinal Disorders
Gastrointestinal disease is the most common health concern that occurs due to environmental, infectious, immunological, psychological, and genetic stress. Among them, the most frequent diseases are gastric ulcer (GU) and ulcerative colitis (UC). DSS-induced UC and ethanol-stimulated GU models resemb...
Autores principales: | Liu, Jingjing, Zhao, Wenyang, Li, Chun, Wu, Tongyu, Han, Liang, Hu, Zhuozhou, Li, Xiangxiang, Zhou, Jing, Chen, Xinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745693/ https://www.ncbi.nlm.nih.gov/pubmed/35008842 http://dx.doi.org/10.3390/ijms23010416 |
Ejemplares similares
-
Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation
por: Wang, Yang, et al.
Publicado: (2022) -
Intraoperative floppy iris syndrome associated with terazosin
por: Venkatesh, Rengaraj, et al.
Publicado: (2007) -
A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6
por: Liao, Liping, et al.
Publicado: (2022) -
Terazosin Treatment Induces Caspase-3 Expression in the Rat Ventral Prostate
por: Papadopoulos, Georgios, et al.
Publicado: (2013) -
Transdermal iontophoresis delivery system for terazosin hydrochloride: an in vitro and in vivo study
por: Jiang, Changzhao, et al.
Publicado: (2021)